- ROUNDTABLE: Pharmacy’s future in sync with technology
- Senate passes Drug Quality and Security Act
- EXPERT BLOG: Provider status for pharmacists — one way or another
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Study from NCPA sheds new light on med synchronization programs
WASHINGTON — The Pharmacy Compounding Accreditation Board is looking for a new executive director following the departure of Joe Cabaleiro, the group said Wednesday.
The formal search will start in January, and the new executive director will oversee accreditation programs for compounding pharmacies and lead compounding initiatives to enhance patient care and improve quality practices. Interested parties may contact National Community Pharmacists Association chief of staff Beverly Martin.
"Pharmacist compounding services, the art of customizing medications for a patient's unique healthcare needs based on a prescriber's order, continues to be in high demand," PCAB president Douglas Hoey said; Hoey is also CEO of the NCPA. "To meet the high standards set forth for PCAB accreditation, an accredited compounding pharmacy has proven that it is providing a valuable healthcare service to its community."